A meta‐analysis and cost‐minimization analysis of bivalirudin versus heparin in high‐risk patients for percutaneous coronary intervention

A meta‐analysis and cost‐minimization analysis of bivalirudin versus heparin in high‐risk patients for percutaneous coronary intervention

Abstract This meta‐analysis was performed to compare the safety, efficacy, and pharmacoeconomic of bivalirudin versus heparin in high‐risk patients for percutaneous coronary interventions (PCI). Earlier meta‐analysis comparing bivalirudin and heparin during PCI demonstrated that bivalirudin caused l...

Full description

Bibliographic Details
Main Authors: Ke‐Xin Sun, Bin Cui, Shan‐Shan Cao, Wen‐Jun Wang, Feng Yu, Jing‐Wen Wang, Yi Ding
Format: Article
Language:English
Published: Wiley 2021-05-01
Series:Pharmacology Research & Perspectives
Subjects:
bivalirudin
economic evaluation
heparin
meta‐analysis
PCI
Online Access:https://doi.org/10.1002/prp2.774

Similar Items

Similar Items